Back to Search Start Over

Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report

Authors :
Guang Zeng
Jie Tang
Shuidong Feng
Liumei Xu
Xiaohui Wang
Zhengrong Yang
Source :
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Publication Year :
2022
Publisher :
Taylor & Francis Group, 2022.

Abstract

In the global context of the COVID-19 pandemic, the overall benefits of getting any COVID-19 vaccine approved by the World Health Organization for emergency use outweigh the potential risks, even in people with weakened immune systems, including people living with HIV (PLWH). At present, there are no reports of HIV/hepatitis B virus (HBV) co-infected patients receiving a booster dose of the inactivated COVID-19 vaccine. Here, we describe a patient with HIV/HBV co-infection who did not seroconvert to three doses of the inactivated COVID-19 vaccine.

Details

Language :
English
ISSN :
21645515 and 2164554X
Volume :
18
Issue :
6
Database :
Directory of Open Access Journals
Journal :
Human Vaccines & Immunotherapeutics
Publication Type :
Academic Journal
Accession number :
edsdoj.833543f4a14b4d35a07c8d7bec9cb74b
Document Type :
article
Full Text :
https://doi.org/10.1080/21645515.2022.2110799